Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for Ulcerative Colitis
NCT04434872Phase 2Terminated
- Sponsor
- Tel Aviv Sourasky Medical Center
- Start
- Jul 2015
- Primary completion
- Jul 2016
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of fecal microbiome transplant in ulcerative colitis (UC), sponsored by Tel Aviv Sourasky Medical Center. Started Jul 2015; status: terminated.
02
Drugs
fecal microbiome transplant
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT04434872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04434872.